Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study to Assess the Safety and Efficacy of Sarilumab in Halting Progression of Morphea

NCT03679845 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT03679845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03679845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study to Assess the Safety and Efficacy of Sarilumab in Halting Progression of Morphea
Lead sponsor
Massachusetts General Hospital
Phase
Phase 1/2
Overall status
Withdrawn
Start date
September 1, 2019
Completion date
June 30, 2021
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

morphea, plaque form